If you or your child has been prescribed hydroxyurea for sickle cell disease (SCD), you probably have questions before starting. What does this medication do? Will it help? What should you watch for once treatment begins?
Here’s what to know about how hydroxyurea works for SCD, who it may help, what treatment involves, and what to ask your healthcare team before you start taking this medication.
Hydroxyurea is a prescription medication that helps reduce some of the complications associated with sickle cell disease. Your healthcare team may also call it hydroxycarbamide or refer to it by brand names like Droxia, Siklos, and Xromi.
Although hydroxyurea was originally developed as a chemotherapy drug to treat certain blood cancers, researchers later discovered that it could help manage SCD by changing how the body produces red blood cells.
Hydroxyurea increases fetal hemoglobin (HbF), a form of hemoglobin present at higher levels before birth. As HbF increases, it can reduce the proportion of hemoglobin S — the type of hemoglobin that causes blood cells to sickle. This can help slow the sickling process.
Hydroxyurea can offer several benefits for people with SCD, including:
Fewer pain crises — It can help reduce how often you experience pain crises, also called vaso-occlusive events. This is when sickled blood cells block blood flow throughout your body.
Lower risk of acute chest syndrome — Hydroxyurea can help lower your chances of developing this serious lung complication.
Fewer hospitalizations — Treatment may reduce how often you’re admitted to the hospital or need emergency care.
Fewer blood transfusions — Hydroxyurea may reduce how often some people need blood transfusions.
Improved quality of life — Fewer pain episodes and hospitalizations may make daily activities easier to manage.
Hydroxyurea is only one part of SCD care. Your healthcare team may recommend other treatments depending on your symptoms and needs.
Not everyone with SCD benefits from hydroxyurea in the same way. Your healthcare provider will look at your SCD type, age, symptoms, and overall health before recommending it.
Research supports early hydroxyurea use for people with sickle cell anemia — including hemoglobin SS disease (HbSS) and hemoglobin S beta-zero thalassemia. They may start treatment as early as infancy, even when symptoms appear mild.
For other genotypes, such as hemoglobin SC disease (HbSC), evidence supporting hydroxyurea treatment remains limited. The decision to use hydroxyurea tends to rely more on your individual symptoms and disease severity.
If hydroxyurea isn’t the right fit or isn’t providing enough benefit on its own, your healthcare team can talk with you about other treatment options, including stem cell transplantation or gene therapy.
Taking hydroxyurea usually involves a daily dose, regular blood tests, and ongoing communication with your healthcare team.
Hydroxyurea is usually taken once daily. Your starting dose depends on factors such as your age, weight, kidney function, and overall health.
Your healthcare provider may gradually increase your dose while monitoring your blood counts. The goal is often to find your maximum tolerated dose — the highest dose you can take without causing blood counts to fall too low or other side effects.
If you have kidney problems, you may need a lower dose. Tell your healthcare team if you have kidney disease and about any other medications you take before starting hydroxyurea.
Regular blood tests help your healthcare team monitor how your body responds to hydroxyurea and whether your dose remains safe.
Your hematologist or another healthcare provider may check your:
Hydroxyurea may lower blood counts at typical doses, but your sickle cell care team will watch closely to keep changes within a safe range.
Once you’re on a stable dose, testing may become less frequent — though you’ll likely need it more often at first or if your dose changes.
Your healthcare team may also monitor your hemoglobin levels and kidney and liver function to guide dose adjustments.
Hydroxyurea works best when taken consistently. Missing doses can reduce medication levels in your system and may affect your treatment response.
You may not notice a difference right away. It can take three to six months of assessing your symptoms and blood tests to know whether treatment is helping.
However, taking your medication every day isn’t always easy. You might forget a dose or experience side effects. Talk with your healthcare team if you’re having difficulty taking your medication daily.
Your healthcare team can help you find an approach that works for you. Here are a few ideas to try:
If you miss a dose, ask your healthcare provider what to do. Don’t double your next dose unless they specifically tell you to.
Before starting treatment, or at any point during treatment, these questions can help guide the conversation with your sickle cell care team:
Bringing a written list to your appointments can help you cover your concerns, especially when you’re starting treatment or considering a change.
Get updates directly to your inbox.
Become a member to get even more
This is a member-feature!
Sign up for free to view article comments.
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.